FDA advisory committee recommends that the FDA approve ivacaftor/lumacator combination therapy
http://www.cysticfibrosis.ca/wp-content/themes/Cystic-Fibrosis-Canada/img/FB_Share_Image.jpg
Yesterday in the US, a Food and Drug Administration (FDA) advisory committee, which is made up of independent medic…
DONATECLOSE
GENERAL DONATIONS
MONTHLY
IN HONOUR
IN MEMORY
Join the CF fight
Cystic fibrosis is the most common fatal genetic disease
affecting Canadian children and young adults
LEARN MORE ABOUT CF > SEE HOW YOU CAN HELP >
Research brings hope
Innovative CF research is bringing us closer to
finding a cure or control
LEARN MORE ABOUT CF RESEARCH > SEE HOW YOU CAN HELP >
Clinical care improves lives
Cystic Fibrosis Canada funds 42 specialized
CF clinics across Canada
Learn more about CF clinical care > SEE HOW YOU CAN HELP >
Advocating for change
Together, we’re raising the voice of Canadians
with cystic fibrosis
LEARN MORE ABOUT ADVOCACY > SEE HOW YOU CAN HELP >
UPCOMING EVENTS
OUR PARTNERS
IN YOUR COMMUNITY
@cysticFibrosisCanada Our 2014 Annual Report is now available! Read about our successes from the past year here: bit.ly/1IRduoo pic.twitter.com/EMb69HOEVQ
May 21st